WO2001079838A1 - Device for detecting analytes related to sample ph - Google Patents
Device for detecting analytes related to sample ph Download PDFInfo
- Publication number
- WO2001079838A1 WO2001079838A1 PCT/US2001/011437 US0111437W WO0179838A1 WO 2001079838 A1 WO2001079838 A1 WO 2001079838A1 US 0111437 W US0111437 W US 0111437W WO 0179838 A1 WO0179838 A1 WO 0179838A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- holding structure
- analyte
- sample
- kit
- assay
- Prior art date
Links
- 239000012491 analyte Substances 0.000 claims abstract description 67
- 238000003556 assay Methods 0.000 claims description 82
- 210000003296 saliva Anatomy 0.000 claims description 71
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims description 70
- 238000012360 testing method Methods 0.000 claims description 61
- 239000000523 sample Substances 0.000 claims description 59
- 229960003920 cocaine Drugs 0.000 claims description 36
- 239000000700 radioactive tracer Substances 0.000 claims description 29
- 239000012488 sample solution Substances 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 17
- 239000008280 blood Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- 238000003018 immunoassay Methods 0.000 claims description 12
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 claims description 12
- 229960001252 methamphetamine Drugs 0.000 claims description 12
- 238000001139 pH measurement Methods 0.000 claims description 10
- 229920002678 cellulose Polymers 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 4
- 210000001124 body fluid Anatomy 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 150000002894 organic compounds Chemical class 0.000 claims description 4
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 claims description 3
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 claims description 3
- 229940012189 methyl orange Drugs 0.000 claims description 3
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 claims description 3
- 231100000614 poison Toxicity 0.000 claims description 3
- 239000003440 toxic substance Substances 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 2
- 238000011109 contamination Methods 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 230000002458 infectious effect Effects 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims 8
- 239000003086 colorant Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 description 45
- 229940079593 drug Drugs 0.000 description 44
- 239000003153 chemical reaction reagent Substances 0.000 description 20
- 210000002381 plasma Anatomy 0.000 description 19
- 239000012528 membrane Substances 0.000 description 12
- 239000011230 binding agent Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000036765 blood level Effects 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 238000003255 drug test Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 239000012042 active reagent Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000006664 bond formation reaction Methods 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000002967 competitive immunoassay Methods 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000012070 reactive reagent Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- KZFBHCCLJSAHBQ-UHFFFAOYSA-N Benzoylecgonine Natural products CN1C2CCC1C(C(C2)OC(=C)c3ccccc3)C(=O)O KZFBHCCLJSAHBQ-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 1
- 229960001736 buprenorphine Drugs 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000009513 drug distribution Methods 0.000 description 1
- GVGYEFKIHJTNQZ-RFQIPJPRSA-N ecgonine benzoate Chemical compound O([C@@H]1[C@@H]([C@H]2CC[C@@H](C1)N2C)C(O)=O)C(=O)C1=CC=CC=C1 GVGYEFKIHJTNQZ-RFQIPJPRSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- -1 enzymes Chemical class 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 229960004715 morphine sulfate Drugs 0.000 description 1
- GRVOTVYEFDAHCL-RTSZDRIGSA-N morphine sulfate pentahydrate Chemical compound O.O.O.O.O.OS(O)(=O)=O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O GRVOTVYEFDAHCL-RTSZDRIGSA-N 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 229950010883 phencyclidine Drugs 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000012206 semi-quantitative assay Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/816—Alkaloids, amphetamines, and barbiturates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/901—Drugs of abuse, e.g. narcotics, amphetamine
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01924835A EP1277052A4 (en) | 2000-04-14 | 2001-04-06 | Device for detecting analytes related to sample ph |
NZ521712A NZ521712A (en) | 2000-04-14 | 2001-04-06 | Device for detecting analytes related to saliva sample pH for measuring drug concentration in blood |
AU2001251453A AU2001251453A1 (en) | 2000-04-14 | 2001-04-06 | Device for detecting analytes related to sample ph |
JP2001576453A JP2003531375A (en) | 2000-04-14 | 2001-04-06 | Detector for sample related to sample pH |
CA002404240A CA2404240A1 (en) | 2000-04-14 | 2001-04-06 | Device for detecting analytes related to sample ph |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/549,725 US6391261B1 (en) | 2000-04-14 | 2000-04-14 | Device for detecting analytes related to sample pH |
US09/549,725 | 2000-04-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001079838A1 true WO2001079838A1 (en) | 2001-10-25 |
Family
ID=24194151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/011437 WO2001079838A1 (en) | 2000-04-14 | 2001-04-06 | Device for detecting analytes related to sample ph |
Country Status (7)
Country | Link |
---|---|
US (1) | US6391261B1 (en) |
EP (1) | EP1277052A4 (en) |
JP (1) | JP2003531375A (en) |
AU (1) | AU2001251453A1 (en) |
CA (1) | CA2404240A1 (en) |
NZ (1) | NZ521712A (en) |
WO (1) | WO2001079838A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040052684A1 (en) * | 2002-09-14 | 2004-03-18 | Sinsky Jerome L. | Diagnostic kit and method of using same |
US20040053417A1 (en) * | 2002-09-14 | 2004-03-18 | Sinsky Jerome L. | Diagnostic device and method of using same |
DE10309349B4 (en) * | 2003-03-03 | 2005-11-10 | Micronas Holding Gmbh | Device for analyzing an analyte |
US7887750B2 (en) * | 2004-05-05 | 2011-02-15 | Bayer Healthcare Llc | Analytical systems, devices, and cartridges therefor |
US20060133338A1 (en) * | 2004-11-23 | 2006-06-22 | Interdigital Technology Corporation | Method and system for securing wireless communications |
US7993283B1 (en) * | 2007-07-23 | 2011-08-09 | Pop Test LLC | Method and apparatus for non-invasive analysis of saliva |
JP5982920B2 (en) * | 2012-03-22 | 2016-08-31 | 王子ホールディングス株式会社 | Absorbent articles |
JP5940861B2 (en) * | 2012-03-30 | 2016-06-29 | アークレイ株式会社 | Saliva secretion promoting device |
JP6117499B2 (en) * | 2012-08-23 | 2017-04-19 | 株式会社Kri | Lifestyle-related disease determination support method using saliva test |
US20160018424A1 (en) * | 2013-03-01 | 2016-01-21 | Compassionate Analytic Inc. | Methods for cannabinoid quantification |
US10073069B2 (en) | 2013-04-23 | 2018-09-11 | Cordant Research Solutions, Llc | Systems and methods to determine body drug concentration from an oral fluid |
WO2019169309A1 (en) * | 2018-03-02 | 2019-09-06 | Berger Russell Jay | Methods, apparatuses and kits for rapid testing of traumatic brain injuries |
WO2024053464A1 (en) * | 2022-09-06 | 2024-03-14 | 日東電工株式会社 | Analysis system and analysis method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5069878A (en) * | 1987-03-24 | 1991-12-03 | Ehrenkranz Joel R L | Integrity preserving and determining urine sample collection apparatus |
US5501985A (en) * | 1990-07-18 | 1996-03-26 | Abbott Laboratories | Analyte-substitute reagent for use in specific binding assay methods, devices and kits |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH065631Y2 (en) * | 1987-03-05 | 1994-02-09 | ライオン株式会社 | Oral inspection tool |
CA1303983C (en) | 1987-03-27 | 1992-06-23 | Robert W. Rosenstein | Solid phase assay |
JPH0746107B2 (en) | 1987-04-27 | 1995-05-17 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Test method |
US4943522A (en) | 1987-06-01 | 1990-07-24 | Quidel | Lateral flow, non-bibulous membrane assay protocols |
JPH0199063U (en) * | 1987-12-24 | 1989-07-03 | ||
CA1331525C (en) * | 1988-05-19 | 1994-08-23 | Joel R. L. Ehrenkranz | Integrity preserving and determining urine sample collection apparatus |
US5252496A (en) | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
US5155022A (en) | 1991-02-08 | 1992-10-13 | Becton, Dickinson And Company | Assay for lyme disease |
US5714341A (en) * | 1994-03-30 | 1998-02-03 | Epitope, Inc. | Saliva assay method and device |
DE4444764A1 (en) * | 1994-12-16 | 1996-06-20 | Moell Claus Juergen | Body fluid analysis test kit, process for its manufacture and analysis process |
US5726062A (en) * | 1995-04-19 | 1998-03-10 | Konica Corporation | Method of detecting protein and a kit detecting protein using the same |
JPH095319A (en) * | 1995-06-20 | 1997-01-10 | Showa Shell Sekiyu Kk | Method and kit for detecting substance to be detected in urine |
JP3536268B2 (en) * | 1995-10-09 | 2004-06-07 | アークレイ株式会社 | Multi-item urine test paper |
US5989840A (en) * | 1997-05-29 | 1999-11-23 | Americare International Diagnostics, Inc. | Estimation of active infection by heliobacter pylori |
JP3786231B2 (en) * | 1997-07-31 | 2006-06-14 | 久光製薬株式会社 | Inspection device |
US6102872A (en) * | 1997-11-03 | 2000-08-15 | Pacific Biometrics, Inc. | Glucose detector and method |
JP2000009727A (en) * | 1998-06-24 | 2000-01-14 | Daikin Ind Ltd | Method for converting saliva component into blood component, device therefor an diagnostic equipment |
US6022326A (en) * | 1998-10-30 | 2000-02-08 | Lifepoint, Inc. | Device and method for automatic collection of whole saliva |
-
2000
- 2000-04-14 US US09/549,725 patent/US6391261B1/en not_active Expired - Fee Related
-
2001
- 2001-04-06 EP EP01924835A patent/EP1277052A4/en not_active Withdrawn
- 2001-04-06 CA CA002404240A patent/CA2404240A1/en not_active Abandoned
- 2001-04-06 JP JP2001576453A patent/JP2003531375A/en active Pending
- 2001-04-06 WO PCT/US2001/011437 patent/WO2001079838A1/en not_active Application Discontinuation
- 2001-04-06 NZ NZ521712A patent/NZ521712A/en unknown
- 2001-04-06 AU AU2001251453A patent/AU2001251453A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5069878A (en) * | 1987-03-24 | 1991-12-03 | Ehrenkranz Joel R L | Integrity preserving and determining urine sample collection apparatus |
US5501985A (en) * | 1990-07-18 | 1996-03-26 | Abbott Laboratories | Analyte-substitute reagent for use in specific binding assay methods, devices and kits |
Non-Patent Citations (1)
Title |
---|
See also references of EP1277052A4 * |
Also Published As
Publication number | Publication date |
---|---|
US6391261B1 (en) | 2002-05-21 |
CA2404240A1 (en) | 2001-10-25 |
NZ521712A (en) | 2004-04-30 |
EP1277052A4 (en) | 2005-06-01 |
JP2003531375A (en) | 2003-10-21 |
EP1277052A1 (en) | 2003-01-22 |
AU2001251453A1 (en) | 2001-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6248598B1 (en) | Immunoassay that provides for both collection of saliva and assay of saliva for one or more analytes with visual readout | |
US20160025752A1 (en) | Devices and methods for detecting and/or quantifying analytes in fluids | |
AU2005225088B8 (en) | Combination assay for alcohol and drugs of abuse | |
EP1891447B1 (en) | Two step lateral flow assay methods and devices | |
US6663831B2 (en) | “One-device” system for testing constituents in fluids | |
EP1307744B1 (en) | Assay apparatus | |
JP4623536B2 (en) | Oral fluid collection device | |
US5962336A (en) | Multi-test panel | |
US20120094303A1 (en) | Device for assaying analytes in bodily fluids | |
JP2009532675A (en) | Integrated screening and confirmation device | |
US6391261B1 (en) | Device for detecting analytes related to sample pH | |
De Giovanni et al. | Cozart Rapiscan system: our experience with saliva tests | |
CA2062900A1 (en) | Saliva testing and fingerprint identification method and device | |
US20030129673A1 (en) | Test apparatus for the detection of pharmacologically active compounds from saliva | |
AU2013229526B2 (en) | Method and device for detecting analytes | |
AU2006201307A1 (en) | Device for detecting analytes related to sample pH | |
JPH1151937A (en) | Inspection device | |
US20060088896A1 (en) | Diagnostic device for rapid determination of buprenorphine | |
AU2002338364B2 (en) | A "one-device" system for testing constituents in fluids | |
DSC-MET | SERATEC® Drug Screen MET | |
AU2002338364A1 (en) | A "one-device" system for testing constituents in fluids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2404240 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 521712 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001251453 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 576453 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001924835 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001924835 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 521712 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 521712 Country of ref document: NZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001924835 Country of ref document: EP |